Stepan (NYSE:SCL – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Friday. Stepan Price Performance Shares of SCL stock traded up $0.53 during trading hours on Friday, hitting $72.87. 155,255 shares of the company’s stock were exchanged, […]

Extreme Networks (NASDAQ:EXTR – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report released on Friday. A number of other analysts have also recently weighed in on EXTR. Craig Hallum raised their target price on shares of Extreme Networks from $17.00 to $22.50 […]

StockNews.com upgraded shares of ANSYS (NASDAQ:ANSS – Free Report) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning. Separately, Rosenblatt Securities dropped their price objective on ANSYS from $345.00 to $335.00 and set a “neutral” rating for the company in a research note on Tuesday, August […]

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a report released on Friday. Other equities analysts have also issued reports about the company. Barclays reduced their price target on Neurocrine Biosciences from $180.00 to $160.00 and set an “overweight” rating […]

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was upgraded by investment analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. A number of other brokerages have also recently issued reports on BIO. Citigroup boosted their target price on shares of Bio-Rad Laboratories […]

YPF Sociedad Anónima (NYSE:YPF – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Friday. Several other research analysts have also recently commented on YPF. Bank of America boosted their price target on shares of YPF Sociedad Anónima from $28.00 to $29.00 […]

StockNews.com upgraded shares of Signet Jewelers (NYSE:SIG – Free Report) from a hold rating to a buy rating in a research report released on Tuesday. Other equities research analysts also recently issued reports about the company. Telsey Advisory Group reiterated a “market perform” rating and issued a $87.00 price objective on shares of Signet Jewelers […]

HC Wainwright restated their buy rating on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note released on Friday morning, Benzinga reports. The firm currently has a $6.00 price objective on the stock. A number of other brokerages have also weighed in on SYRS. JMP Securities dropped their price objective on Syros […]

StockNews.com lowered shares of Norwegian Cruise Line (NYSE:NCLH – Free Report) from a hold rating to a sell rating in a research report sent to investors on Wednesday. NCLH has been the topic of several other research reports. Susquehanna boosted their price objective on Norwegian Cruise Line from $18.00 to $19.00 and gave the company […]

HC Wainwright reiterated their buy rating on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $22.00 price target on the stock. A number of other equities research analysts have also issued reports on WVE. B. Riley increased their […]

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a note issued to investors on Friday, Benzinga reports. They currently have a $190.00 target price on the stock. HC Wainwright’s price objective suggests a potential upside of 57.98% from the company’s current price. […]

StockNews.com upgraded shares of TETRA Technologies (NYSE:TTI – Free Report) from a sell rating to a hold rating in a research note published on Wednesday morning. Separately, EF Hutton Acquisition Co. I upgraded shares of TETRA Technologies to a “strong-buy” rating in a report on Monday, October 21st. Read Our Latest Stock Analysis on TTI […]

StockNews.com downgraded shares of Sherwin-Williams (NYSE:SHW – Free Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday. Other research analysts have also recently issued research reports about the stock. Morgan Stanley raised their price target on shares of Sherwin-Williams from $375.00 to $450.00 and gave the […]

Manitowoc (NYSE:MTW – Get Free Report) was upgraded by research analysts at StockNews.com from a “sell” rating to a “hold” rating in a report issued on Friday. MTW has been the subject of a number of other research reports. Robert W. Baird cut their price objective on shares of Manitowoc from $13.00 to $12.00 and […]

StockNews.com cut shares of Lakeland Industries (NASDAQ:LAKE – Free Report) from a hold rating to a sell rating in a report published on Tuesday morning. Separately, Roth Mkm lifted their price objective on shares of Lakeland Industries from $25.00 to $27.00 and gave the stock a “buy” rating in a research report on Wednesday, July […]

Arvinas (NASDAQ:ARVN – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a note issued to investors on Thursday, Benzinga reports. They presently have a $87.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 223.42% from the company’s previous close. Other equities […]

HC Wainwright reissued their buy rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $55.00 price objective on the stock. Several other research firms have also weighed in on BCYC. Oppenheimer restated an “outperform” rating and issued a $48.00 target price on […]

Stephens upgraded shares of Regions Financial (NYSE:RF – Free Report) from an equal weight rating to an overweight rating in a research note issued to investors on Tuesday, Marketbeat.com reports. Stephens currently has $26.00 price objective on the bank’s stock. Several other research firms also recently weighed in on RF. Citigroup lifted their target price […]

HC Wainwright reiterated their buy rating on shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) in a report issued on Thursday, Benzinga reports. The brokerage currently has a $157.00 target price on the biotechnology company’s stock. LGND has been the subject of a number of other reports. Oppenheimer initiated coverage on Ligand Pharmaceuticals in a […]